1. Scrip

Gene And Cell Therapies In Asia: New Korean Law To Change Landscape Of Cutting Edge Biologics

Invossa Affair Still Hangs Heavy

 
• By Jung Won Shin

South Korea will undergo many changes as it gears up for a new law on cutting edge regenerative medicine and biologics, which will be implemented next year. Until then, further discussions will be needed to set details of the rules that can step up the industry’s competitiveness and bring the country more in line with global standards.

Map_Asia_Pin
Substantial Changes Seen For Gene, Cell Therapies In Korea With New Law • Source: Shutterstock

The South Korean regulatory environment for cell and gene therapies is poised to change substantially through a new Cutting Edge Regenerative Medicine and Biologics Act to be introduced next year. 

But until the new law is fully implemented in August 2020, further discussions across multiple areas will be needed to set details of rules that can step up the local industry’s international competitiveness and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Focus On Asia